Regulatory Briefs: FDA Plans To Study Explanted Hips, Announces Upcoming Meetings

FDA is seeking applicants to help run an explant analysis study on hip implants. The agency plans a workshop on incorporating patient preference into CDRH regulatory decisions and a meeting with health professional organizations. More regulatory news.